Shilpa Keerthivasan to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Shilpa Keerthivasan has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.062
-
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med. 2020 05; 26(5):693-698.
Score: 0.031
-
Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature. 2020 03; 579(7798):274-278.
Score: 0.031